Navigation Links
Omnicare and AmerisourceBergen Under Review: Drugs Company Stocks Hit New Highs
Date:2/21/2013

LONDON, February 21, 2013 /PRNewswire/ --

Health-care reforms are expected to bring about paradigm shift in healthcare sectors. However, the major companies are well prepared for such changes. Among others, wholesale drug companies are looking to consolidate their positions in order to be better equipped to face challenges. The stocks are trading on their highs on account of the good performance. AmerisourceBergen Corporation (NYSE: ABC) reported good results and a new collaboration with PharMerica. Similarly, Omnicare Inc. (NYSE: OCR) is getting lapped up Hedge Funds. The stocks are expected to keep up the momentum and perform well. StockCall has released free charting and technical research on these two aforementioned companies. Register to read these reports at

http://www.stockcall.com/report  

AmerisourceBergen Inks Deal with Express Script

AmerisourceBergen's stock hit a new 52-week high. The stock is up 28 percent in the past 52 weeks and seems to maintain the streak. The company also recently announced a 21 cent per share dividend payable on March 4th. Its dividend yield stands at 1.80 percent. AmerisourceBergen reported its fiscal first quarter revenue at $21.5 billion, up 5 percent from $20.3 billion reported a year earlier. Its net income also increased from 62 cents per share to 71 cents apiece. For fiscal 2013, the company expects its earnings to be at $3.16 per share, beating expectations of $3.13 per share. AmerisourceBergen Corporation free technical report can be accessed by signing up at http://www.StockCall.com/ABC022113.pdf  

AmerisourceBergen is expected to keep performing well as the company won a major contract with Express Scripts. The company also renewed its deal with PharMerica, which ensure that the company remains the primary vendor for pharmaceuticals for PharMerica. The deal also makes AmerisourceBergen the primary vendor for California-based Amerita.

AmerisourceBergen is expected to face some tailwinds once health reforms kick in. It also has thin margins and therefore has lesser cushion. However, the company stock is expected to perform well despite its recent run up.

Omnicare Garners Hedge Fund Interest

Omnicare reported good results for its fourth quarter. The company reported its EPS at 86 cents per share, up from 56 cents per share it had reported a year earlier. Its revenue stood at $1.53 billion, down 1.74 percent. The stock has been hitting new 52-week highs lately. It had also been garnering good institutional interest as well. Hedge fund Iridian Asset Management augmented its holding of the company's stock. Omnicare's stock is also held by First Pacific Advisors. Hedge Fund buying is generally considered to be a positive sign for the future growth of the stock. Another major holder of the stock is Oaktree Capital Management. Sign up for the free report on Omnicare Inc. at http://www.StockCall.com/OCR022113.pdf  

However, Omnicare faces some challenges as well. The company is currently restructuring its business to curtail its costs. Late last year, it closed some of its offices and reduced headcounts. It also changed its top management and made some key appointments. The company deals in pharmaceutical care and is mainly operational in Canada and the U.S. It also operates chronic care facilities.

Omnicare's stock gained 6 percent this year so far and is up 11 percent in the past 12 months. The stock also offers 1.45 percent dividend yield. Omnicare recently announced 14 cents per share in quarterly dividend.

About StockCall.com

StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines. Sign up today to talk to our financial analyst at http://www.stockcall.com


'/>"/>
SOURCE StockCall.com
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Faruqi & Faruqi, LLP is Investigating AmerisourceBergen Corporation on Behalf of its Shareholders
2. Silver Lining Textiles, Manufacturers of Anti-microbial Under Scrub Garments for the Healthcare Industry, Announces Their Availability Through Amazon.com
3. National Patient Advocate Foundation Supports 340B Drug Discount Program Review Identifying Risks to Underinsured Patients
4. Founder of Nestle-Acquired Company Joins Prismic Pharmaceuticals
5. Amgen and Peregrine Under StockCall Scrutiny: Pharma Stocks Deal with Drug Developments and Patents
6. NewLink Genetics Corporation Announces Exercise of Underwriters Option and Closing of Public Offering of Common Stock
7. Underage Kids Get Hydrocodone Drugs Easily from Family & Friends, Advises New York Center for Living
8. Nearly Half of Children Under 2 Years of Age Receive Some Vaccinations Late
9. Starkey Hearing Foundation Founders Bill and Tani Austin Honored by Dalai Lama After Recent Hearing Mission to India
10. Key patent awarded to Adjuvance co-founders for pioneering method of producing rare vaccine component.
11. PIMCO founder Bill Gross and wife, Sue, make transformational gift to Cedars-Sinais Advanced Health Sciences Pavilion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/6/2017)... NeuroRx, a clinical stage biopharma company developing the first oral ... granted Fast Track status by the US Food and Drug ... by NRX-101 (D-cycloserine + lurasidone). The company will shortly begin ... targeting patients who are admitted to Emergency Departments with ASIB ... ...
(Date:9/5/2017)... Sept. 5, 2017 Sapheneia and Scannerside received ... Scannerside DoseCheck is a third-party Vendor neutral CT product ... and allows compliance with current MITA standards. ... 29 DoseCheck solution is specifically designed to provide CT ... potential radiation doses over a predefined threshold. Scannerside Dose ...
(Date:9/5/2017)... WAYNE, N.J. , Sept. 5, 2017 /PRNewswire/ ... technology, has created a vibrant charitable donation program ... funds and support congenital heart defect research by ... healthcare providers and the general public are encouraged ... and submit the completed artwork to the ...
Breaking Medicine Technology:
(Date:9/21/2017)... ... September 21, 2017 , ... Innovatum will demonstrate capabilities of ... Healthcare Conference 2017 in Chicago, IL on October 17-19, 2017. This unique development ... improving patient safety. , Microscan , a global technology leader in ...
(Date:9/21/2017)... ... ... FlipBelt, the fitness brand that specializes in problem solving fitness accessories, has ... the launch of their FlipBelt Crops. , The new fitness bottoms feature an integrated ... at the gym, on the trail, or on-the-go. , “We always thought the FlipBelt ...
(Date:9/20/2017)... ... 2017 , ... FirstAlign ( http://www.firstalign.com ), combines strategies and ... (AI) thinking, announced today the launch of its revamped web presence. , ... offers a more comprehensive understanding of the organization’s business and machine learning solutions. ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... company specializing in medical device compliance and commercialization, has just released a ... activities. , FDA is more adamant than ever about medical device, pharmaceutical, ...
(Date:9/20/2017)... ... 2017 , ... Compliancy Group is proud to announce that ... helped another long-time client pass their Department of Health and Human Services (HHS) ... Thanks to the help of the Compliancy Group's Audit Response Program™, not a ...
Breaking Medicine News(10 mins):